Howsiya Sethukavalan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 |
Dr. Navin Ramlal, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 |
Ayn Morato, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 |
Sourabh Bidhan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4864 Jackson St, Monroe, LA 71202 Phone: 346-351-0795 |
Dr. Nilgun Camilla Frengell, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4000 |
Sharon Kaye Joiner, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St., Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 |
Michael D O'neal Ii, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Hospitalist, Monroe, LA 71201 Phone: 318-966-4540 Fax: 318-966-4543 |
Dr. Mohammad Nour A Salloum, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 |
Madan Mohan Reddy Koppolu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4000 |
Aditya Rander, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 309 Jackson St, Monroe, LA 71201 Phone: 318-966-4541 Fax: 318-966-4543 |
Lynzie Elizabeth Boudreaux, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 295 Indest St, New Iberia, LA 70563 Phone: 337-365-0268 Fax: 337-369-6922 |
Dr. Brian Thomas Halbert, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3910 Fax: 504-842-4533 |
Dr. Diane Davis Van Gerwen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-7518 |
Robert Lawrence Marier, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 |
Corey Gregg, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St, New Orleans, LA 70112 Phone: 954-551-1683 |
Dr. Marianne Maumus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 |
Dr. Ryan Stephen Kissee, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, Sl 50, New Orleans, LA 70112 Phone: 504-988-7809 Fax: 504-988-3971 |
Jordan Callender, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Ave, Room 436, New Orleans, LA 70112 Phone: 504-568-7884 |
Rachel Dayno, Hospitalist Medicare: Medicare Enrolled Practice Location: 1430 Tulane Ave # Sl50, New Orleans, LA 70112 Phone: 504-988-7809 Fax: 504-988-3971 |
David James Montgomery Jr., Hospitalist Medicare: Medicare Enrolled Practice Location: 2000 Canal St, New Orleans, LA 70112 Phone: 504-702-3000 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today presented a poster on dual Erk/PI3K inhibitors and made an oral presentation on its selective Erk inhibitors, at the American Association for Cancer Research Annual Meeting in Washington, D.C.
Seaweed has long been a staple food in many Asian countries and has recently caught on as a snack food in America as a healthful alternative to chips. The edible algae that fall in the category of seaweed are low-calorie and packed with nutrients
Drugs that work by blocking the function of a protein from the outside also disrupt the protein's internal workings, according to new research from the University of North Carolina at Chapel Hill.
Patients with stage III colon cancer treated with 5-FU-based chemotherapy after complete surgical removal of their tumor after 1995 had improved overall survival with no change in time to recurrence compared to patients treated before 1995. In contrast, patients with stage II colon cancer treated after 1995 had longer time to recurrence and time from recurrence to death compared to those patients treated prior to 1995, according to Mayo Clinic and Gr Hospitalier Pitie-Salpetriere, Paris, researchers.
StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC ProvenĀ® cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use in drug screening and drug development. These initiatives reflect the Company's ongoing integration of the operations acquired from Stem Cell Sciences (SCS) Plc in April, and include new personnel appointments and a realignment of activities within the Company's Cambridge, UK and Palo Alto, California locations.
› Verified 2 days ago